NCT07350746

Brief Summary

Preservation of pulp vitality through vital pulp therapy (VPT) has emerged in contemporary endodontics, particularly for immature permanent teeth. In cases of irreversible pulpitis, recent literature suggests that clinical symptoms do not always correlate with histopathological findings, supporting the use of conservative approaches such as full pulpotomy. This is especially relevant in young patients where continued root development and apical closure are critical for long-term tooth integrity and functionality. Immature teeth, due to their high cellularity and vascularity, exhibit a greater regenerative capacity, making them indicated for biologically based treatments. Among the materials used for VPT, calcium silicate-based cements (CSCs) have demonstrated good biological and physicochemical properties, including high biocompatibility, antimicrobial effects, alkaline pH, and sustained release of calcium ions that stimulate biomineralization. Mineral Trioxide Aggregate (MTA) has long been considered the gold standard; however, it is associated with several clinical limitations such as extended setting time, complex handling, and potential tooth discoloration. To address these drawbacks, newer generation premixed bioceramics have been introduced. These include NeoPUTTY®, Total Fill® BC UNIVERSAL RRM™, and Bio-C® Repair, each exhibiting unique compositional and functional properties designed to enhance clinical performance and ease of use. Despite promising individual results, no clinical study has yet compared these three materials within the context of pulpotomy in immature permanent molars with irreversible pulpitis. This randomized clinical trial aims to fill this gap by evaluating their clinical and radiographic outcomes over a 12-month period, to better guide material selection in vital pulp therapy.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
10mo left

Started Oct 2025

Typical duration for not_applicable pain

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Oct 2025Feb 2027

Study Start

First participant enrolled

October 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 29, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 20, 2026

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 27, 2027

Last Updated

January 20, 2026

Status Verified

January 1, 2026

Enrollment Period

1.4 years

First QC Date

November 29, 2025

Last Update Submit

January 9, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • -Root formation and apical closure.

    Continued root formation and apical closure will be assessed using standardized periapical radiographs of the treated immature permanent molars and classified according to Cvek's stages of root development. Radiographic evaluation will be performed by a calibrated examiner. Progression in root development will be determined by changes in root length and apical foramen morphology compared with baseline. Cvek's classification includes five radiographic stages of root development: Stage I (A): \< 1/2 root length Stage II (B): 1/2 root length Stage III (C): 2/3 root length Stage IV (D): Nearly complete root length with wide open apical foramen Stage V (E): Complete root development with closed apical foramen

    12 months

  • -Postoperative pain. -Percussion and/or palpation pain.

    Pain response will be recorded as a binary outcome (Yes/No) based on the patient's subjective report during standardized clinical examination. The assessment will be performed by a calibrated examiner using gentle vertical percussion and periapical palpation according to routine endodontic diagnostic procedures. Measurement Tool Clinical percussion test Clinical palpation test Patient-reported pain response during examination (verbal report) Postoperative pain assessed using a Visual Analog Scale (VAS) ranging from 0 (no pain) to 10 (worst pain imaginable), recorded by the patient.

    12 months

Other Outcomes (1)

  • -Presence of periapical lesion.

    12 months

Study Arms (3)

Neo PUTTY (Nusmile Inc, Houston, TX; USA)

EXPERIMENTAL

premixed bioactive bioceramic composed of an inorganic powder containing tricalcium and dicalcium silicate in a water-free organic liquid.

Device: Neo PUTTY (Nusmile Inc, Houston, TX; USA)

Total Fill® BC UNIVERSAL RRM™ (FKG Dentaire, Switzerland)

ACTIVE COMPARATOR

premixed bioceramic material composed of calcium aluminosilicate paste designed for permanent root canal repair and surgical applications.

Device: Total Fill® BC UNIVERSAL RRM™ (FKG Dentaire, Switzerland)

Bio-C® Repair (BCR; Angelus, Londrina, Brazil)

ACTIVE COMPARATOR

new ready-to-use bioceramic repair material. Bio-C has indications similar to MTA and is composed of calcium silicates \[tricalcium silicate, dicalcium silicate\], tricalcium aluminate, calcium oxide (for the release of calcium ions), and zirconium oxide as a radioopacifier.

Device: Bio-C® Repair (BCR; Angelus, Londrina, Brazil)

Interventions

To the best of our knowledge, no study has yet compared these three biomaterials in the treatment of permanent molars with incomplete root development.

Neo PUTTY (Nusmile Inc, Houston, TX; USA)

To the best of our knowledge, no study has yet compared these three biomaterials in the treatment of permanent molars with incomplete root development.

Bio-C® Repair (BCR; Angelus, Londrina, Brazil)

To the best of our knowledge, no study has yet compared these three biomaterials in the treatment of permanent molars with incomplete root development.

Total Fill® BC UNIVERSAL RRM™ (FKG Dentaire, Switzerland)

Eligibility Criteria

Age7 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Healthy patients (according to ASA classification) with noncontributory medical history.
  • Patients aged between 7 and 11 years of age, with at least one immature permanent molar with deep caries, needing full pulpotomy.
  • Cooperative pediatric patients (Frankl's behavioral rating scale).
  • Restorable immature permanent molar with deep caries: caries involving the pulpal roof or where complete caries removal would likely result in pulpal exposure.
  • Physiological mobility.
  • Vital pulp (detected by clinical signs/symptoms) presenting symptoms classically indicative of irreversible pulpitis according to AAE diagnostic criteria : positive but heightened response to cold sensibility testing, presence of spontaneous pain.
  • No clinical signs of pulp necrosis; absence of a sinus tract or swelling.
  • Patients who agree to return for periodic examination (follow-up).
  • Patients who are willing to sign the consent form (written informed consent).

You may not qualify if:

  • Medically compromised patients.
  • Patients older than 11 years or younger than 7 years of age.
  • Mature permanent molar.
  • No signs and symptoms of irreversible pulpitis.
  • No pulp exposure even after complete caries excavation.
  • Clinical signs of pulp necrosis on the tooth to be treated, such as insufficient bleeding or no bleeding after pulp exposure.
  • Uncontrollable pulp hemorrhage (more than 10 minutes of hemostasis).
  • Teeth previously endodontically treated.
  • Teeth with pathological root resorption.
  • Impossibility to place a rubber dam.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universite Saint Joseph de Beyrouth

Beirut, Lebanon

Location

MeSH Terms

Conditions

Pain

Interventions

International Normalized Ratio

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Blood Coagulation TestsHematologic TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 29, 2025

First Posted

January 20, 2026

Study Start

October 1, 2025

Primary Completion (Estimated)

February 27, 2027

Study Completion (Estimated)

February 27, 2027

Last Updated

January 20, 2026

Record last verified: 2026-01

Locations